Presentations :: Benitec Biopharma Inc. (BNTC)

Mar 19, 2025

Interim Study Update for BB-301 Gene Therapy Phase 1b/2a First in Human Trial in Subjects with Oculopharyngeal Muscular Dystrophy with Dysphagia

Mar 5, 2025

Corporate Presentation, March 2025

Oct 14, 2024

Interim Clinical Data Summary for Subject One and Two

Apr 18, 2024

Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy

Jan 6, 2024

Corporate Presentation, January 2024

Jul 9, 2023

Corporate Presentation, July 2023

Jan 5, 2023

Corporate Presentation, January 2023

Jun 27, 2022

Corporate Presentation, June 2022

Sep 8, 2021

Corporate Presentation, September 2021

Feb 24, 2021

Interim Results of IND-Enabling Large Animal Study for BB-301

Select a page